(Q47226272)

12 January 2018

title

BRCA1 185delAG mutation inhibits Akt-dependent, IAP-mediated caspase 3 inactivation in human ovarian surface epithelial cells (English)

1 reference

12 January 2018

1 reference

Nicole C Johnson

1

1 reference

12 January 2018

Han C Dan

series ordinal

2

1 reference

12 January 2018

Jin Q Cheng

series ordinal

3

1 reference

12 January 2018

Patricia A Kruk

series ordinal

4

1 reference

12 January 2018

language of work or name

English

0 references

publication date

1 August 2004

1 reference

12 January 2018

Experimental Cell Research

published in

1 reference

12 January 2018

volume

298

1 reference

12 January 2018

issue

1

1 reference

12 January 2018

page(s)

9-16

1 reference

12 January 2018

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

1 reference

Caspase-mediated apoptosis in the vertebrate ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

Failure of poly(ADP-ribose) polymerase cleavage by caspases leads to induction of necrosis and enhanced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

The IAP family: endogenous caspase inhibitors with multiple biological activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

XIAP: apoptotic brake and promising therapeutic target.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

BRCA1 Facilitates Stress-induced Apoptosis in Breast and Ovarian Cancer Cell Lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

Tumorigenesis in mice carrying a truncating Brca1 mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

Effect of BRCA Mutations on the Length of Survival in Epithelial Ovarian Tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations ofBRCA1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

Identification of the 185delAG BRCA1 mutation in a Spanish Gypsy population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

Identification of germline 185delAG BRCA1 mutations in non-Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

Simian virus 40-transformed human ovarian surface epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation into the endoplasmic reticulum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

Apoptosis: checkpoint at the mitochondrial frontier.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

Transferring substrates to the 26S proteasome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.04.003

10.1016/J.YEXCR.2004.04.003

7 January 2021

Identifiers

DOI

1 reference

12 January 2018

1 reference

12 January 2018